Apptly raises first $511K tranche of private placement, insiders chip in
What's the deal? Apptly Health TechnologiesDealroom has a profile for this one. Try Dealroom →, listed on the Canadian Securities ExchangeDealroom has a profile for this one. Try Dealroom → and Frankfurt Stock ExchangeDealroom has a profile for this one. Try Dealroom →, has closed the first tranche of a non-brokered private placement, raising US$532.7K (roughly $511,000). It issued 5,811,600 units at US$0.09 each, with each unit comprising one common share and one warrant.
How the warrants work: Each warrant lets holders buy one share at US$0.18 for 12 months after the October 6, 2026 closing date. Apptly can accelerate expiry if its share price holds at or above US$0.26 for 30 consecutive trading days.
Who's in? Interim chief executive officer and director Paula Muto subscribed for 1,071,600 units, investing US$98.2K. An existing 10% shareholder put in US$73.3K for 800,000 units. Both count as related-party transactions under Canadian securities rules, though the raise was exempt from valuation and minority-approval requirements as its fair market value fell below US$1.83M.
What's the money for? Net proceeds will go primarily toward general working capital. Apptly paid US$2.18K in finder's fees and issued 23,800 broker warrants to an arm's-length party.
Why now? The company expects to close a second tranche in the coming weeks, subject to customary conditions and any required regulatory approvals. Securities from the first tranche carry a four-month-and-one-day hold period.
The signal: At roughly $511,000, this is a modest raise — landing in the bottom tenth of funding rounds by size. Insider participation signals internal confidence, but the small, working-capital-focused placement points to a company funding near-term operations rather than scaling.
Read more: newsfilecorp.com
Image credit: Generated with Gemini
